HOPO Cas 13161-30-3
Product Description
Hunan Ouya Pharmaceutical Co., Ltd
-
CN -
2023On CPHI since
-
1Certificates
-
100 - 249Employees
Company types
Primary activities
Categories
Specifications
Hunan Ouya Pharmaceutical Co., Ltd
-
CN
-
2023On CPHI since
-
1Certificates
-
100 - 249Employees
Company types
Primary activities
More Products from Hunan Ouya Pharmaceutical Co., Ltd (4)
-
Product Enzalutamide intermediate/Cas 143782-23-4
Anticancer Intermediates -
Product Fulvestrant Intermediates/Cas 875573-67-4
Anticancer Intermediates -
Product Olaparib intermediate/Cas 763114-25-6
intermediates -
Product Olmesartan Medoxomil
Cardiovascular
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance